##semicolon##
ревматоидный артрит, активность, каль- протектин.##submission.citations##
1. Berntzen HB, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheuma- tol.1989;16:1416-20.
2. Berntzen HB, Fagerhol MK, Ostensen M et al. The L1 pro- tein as a new indicator of infl ammatory activity in patients with ju patients with juvenile rheumatoid arthritis. J Rheuma- tol.1991;18:133-8.
3. Brun JG, Haga HJ, Boe E et al. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory vari- ables of disease arthrity. J Rheumatol.1992;19:859-62. 8
4. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease arthrity in patients with infl ammatory rheumatic disease. J Rheuma- tol.1994;21:733-7.
5. De Jong PH, Hazes JM, van Zeben D at al. Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 clas- sification criteria. Rheumatology (Oxf.).2012;51(7):1269-77. DOI: 10.1093/rheumatology/kes008.
6. Fransen J, Stucki G, van Riel PLCM. Rheumatoid arthri- tis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR) and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Rheum.2003;49:214-24. DOI: 10.1002/art.11407.
7. Marks JL, Holroyd CR, Dimitrov BD et al. Does combined clinical and ultrasound assessment allow selection of indi- viduals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy? Arthritis Care Res. (Hobo- ken).2015;67(6):746-53. DOI: 10.1002/acr.22552.
8. Prevoo ML, van‘t Hof MA, Kuper HH et al. Modified dis- ease activity scores that include twenty-eight-joint counts.
Development and validation in a prospective longitudi- nal study of patients with rheumatoid arthritis. Arthritis Rheum.1995;38(1):44-8. DOI: 10.1002/art.1780380107. PMID: 7818570.
9. Smolen JS, Aletaha D, Bijlsma JW et al. T2T Expert committee. Treating rheumatoid arthritis to target: recom- mendations of an international task force. Ann. Rheum. Dis 2010;69(4):631-7. DOI: 10.1136/ard.2009.123919.